ArticleClinical pharmacology : advances and applications2019

Modeling and simulation of the endogenous CYP3A induction marker 4β-hydroxycholesterol during enasidenib treatment.

Yan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.